Log In

Forgot Password?
Create New Account

Loading... please wait

2018 Annual Meeting | C219 - The Early-Onset Dementias

Friday 04/27/18
07:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Mario F. Mendez, MD, PhD, FAAN
Participants should be able to recognize early-onset dementias and their variable presentations, formulate a differential diagnosis, know when to use and apply new biomarkers and genetic tests, and be able to apply management strategies applicable to early-onset dementias.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Advanced Practice Provider
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist
Case-based, Didactic, Audience Participation
Event Timeline
07:00 AM - 07:50 AM Speaker Early-Onset Dementias and Alzheimer Variants
Mario F. Mendez, MD, PhD, FAAN
07:50 AM - 08:00 AM Q&A Questions and Answers
08:00 AM - 08:50 AM Speaker The Frontotemporal Degenerations
Murray Grossman, MD, FAAN
08:50 AM - 09:00 AM Q&A Questions and Answers
09:00 AM - 09:00 AM Closing Remarks Closing Remarks
Faculty Disclosures
Mario F. Mendez, MD, PhD, FAAN Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Education Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.